The insulin -like growth factor I receptor ( IGF -IR ) plays an essential role in the establishment and maintenance of transformed phenotype of Ewing's sarcoma ( ES ) cells, and interference with the IGF -IR pathways by a neutralizing antibody causes reversal of the malignant potential of this neoplasm. In this paper, we stably transfected an IGF -IR antisense mRNA expression plasmid in an ES cell line to determine the effectiveness of antisense strategies against the in vitro and in vivo growth of ES cells. Doxorubicin sensitivity of TC -71 cells expressing antisense targeted to IGF -IR mRNA was also examined. Cells carrying antisense IGF -IR had a reduced expression of the receptor, a modest decrease in cell proliferation, a significant increase in anoikis -induced apoptosis, and a severely reduced ability to form colonies in soft agar. Moreover, TC / AS cells showed a marked reduction in their motility. In vivo, when cells carrying antisense IGF -IR were injected subcutaneously in nude mice, tumor formation was delayed and survival increased. Metastatic ability of ES cells was also significantly reduced. Furthermore, TC / AS clones showed a significantly higher sensitivity to doxorubicin -a major drug in the treatment of ES. These results indicate that inhibiting IGF -IR by antisense strategies may be relevant to the clinical treatment of ES patients by reducing the malignant potential of these cells and enhancing the effectiveness of chemotherapy. Cancer Gene Therapy ( 2002 ) 9, 296 -307 DOI: 10.1038 / sj / cgt / 7700442
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as well as the expression, at extremely high levels, of an antigen encoded by the MIC2 gene (also known as CD99 or p30 /32 MIC2 ). 2, 3 ES shows an extremely aggressive clinical course. At diagnosis, approximately 25% of patients has detectable metastases in the lungs and /or bones and bone marrow, but nearly all patients have micrometastases, as evidenced by a less than 10% cure rate with local therapy alone. 4 The adoption of multimodal treatments with very aggressive chemotherapeutic regimens associated with surgery or radiotherapy for local control has significantly improved the chance of survival of ES nonmetastatic patients, shifting the 5 -year survival rate to around 50 -60%. 5, 6 However, despite advances in therapy, one third of patients with nonmetastatic disease, and the great majority of patients with metastases at diagnosis, do not survive, regardless of therapy. 7 Furthermore, recent clinical studies have indicated that the survival rate of ES patients has reached a plateau phase and, possibly, the highest levels achievable by conventional multimodal therapy. 8, 9 Successful treatment of therapy -resistant disease therefore requires new strategies.
Recent findings have indicated the insulin -like growth factor I receptor I ( IGF -IR ) as a promising target for tailored biological therapies of ES. IGF -IR is implicated in the autocrine and paracrine control of ES growth and appears to be particularly important in the pathogenesis of this tumor. In particular, IGF -IR -mediated loop is constantly present in ES and is a major autocrine circuit of this neoplasm. 10, 11 In addition, Toretsky et al 12 reported IGF -IR expression to be necessary for EWS /FLI -1-mediated transformation of primary fibroblasts. Thus, the IGF -IR pathway may be considered a good site for therapeutic intervention in EWS -FLI -1-mediated tumor proliferation. We confirmed this finding by demonstrating that impairment of IGF -IR by neutralizing antibody and suramin reduces growth and increases apoptosis of ES cells both in vitro and in vivo, and significantly decreases migration, invasion, and metastatic spread to the lungs and bones. 13 In this study, we explored the preclinical effectiveness of antisense IGF -IR therapy both in terms of inhibition of the in vitro and in vivo growth of ES cells and by increasing their sensitivity to conventional chemotherapeutic agents.
Materials and methods

Cell line and transfection
ES cell line TC -71 was a generous gift from TJ Triche ( Children Hospital, Los Angeles, CA ). Cells were routinely cultured in Iscove modified Dulbecco's medium (IMDM ), supplemented with 100 U / mL penicillin, 100 g/mL streptomycin (Life Technologies, Paisley, Scotland, UK ), and 10% inactivated fetal calf serum (FCS ) (Biological Industries, Kibbutz Beth Haemek, Israel). TC -71 cells were maintained in a humidified 5% CO 2 atmosphere. We also used cell lines derived from TC -71, expressing an antisense or a sense mRNA to the IGF -IR mRNA. These cell lines were obtained by a calcium phosphate transfection with a plasmid (HSPIGF -IR; kindly gifted from R Baserga, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA ) that contains a 309 -bp fragment of a human IGF -IR cDNA in either the sense or antisense direction, under the control of the Drosophila HSP70 promoter. These cells were cultured in IMDM plus 10% FCS plus 500 g/ mL G418 (Sigma, St. Louis, MO ) to maintain stable transfectants.
Polymerase chain reaction ( PCR )
PCR was performed to verify the presence of the plasmid in the transfectants. Genomic DNA was extracted by DNAzol extraction kit (Life Technologies ), according to the manufacturer's instructions. DNA (500 ng ) was amplified by PCR using the amplimers previously reported.
14 The expected PCR product size is 172 bp; because the amplimers are in different exons separated by a large intron, only plasmid DNA is detected by this method. PCR was performed with a 558C annealing temperature for 40 amplification cycles.
Quantitative real -time RT -PCR
Total RNA was extracted by TRIzol extraction kit (Life Technologies ) from IGF -IR sense and antisense transfectants maintained at 358C ( controls ) and 39.68C, a temperature reported to induce the expression of sense and antisense transcripts, 14, 15 for 72 hours. The quality of the RNA samples was determined by electrophoresis through agarose gels and staining with ethidium bromide, and the 18S and 28S RNA bands were visualized under UV light. Real-time fluorescence detection method 16, 17 was used to analyze the relative level of IGF -IR expression in our transfectants. In particular, 1 g of total RNA was denatured at 658C for 10 minutes and then reversetranscribed in a 100 -L reaction mixture containing 500 M of each dNTP, 125 U of MultiScribe Reverse Transcriptase (Applied Biosystems, Foster City, CA ), 40 U of RNase Inhibitor (Applied Biosystems), 2.5 M oligo d(T ) 16 , 1Â TaqMan RT Buffer, 5 mM MgCl 2 at 488C for 40 minutes. Reactions omitting enzyme or RNA were used as negative controls. TaqMan primers and probes for the quantitative detection of human glyceraldehyde -3 -phosphate dehydrogenase (GAPDH ) and IGF -IR were designed by using Primer Express software ( Applied Biosystems ) to work in the same cycling conditions (958C for 10 minutes followed by 40 cycles at 958C for 15 seconds and 608C for 1 minute ) generating products with sizes of 224 and 70 bp, respectively. PCR primer and probe sequences were as follows ( all 5 0 to 3 0 direction ): IGFIR: forward GAA AGT GAC GTC CTG CAT TTC A, reverse CCG GTG CCA GGT TAT GAT G, probe: FAM -TCC ACC ACC ACG TCG AAG AAT CGC; GAPDH: forward GAA GGT GAA GGT CGG AGT C, reverse GAA GAT GGT GAT GGG ATT TC, probe: FAM -GAA GCT TCC CGT TCT CAG CC.
All PCR reactions were performed by using a ABI PRISM 7700 Sequence Detection System ( Applied Biosystems ). Standard curves for both target and reference gene were made by using 5-fold serial dilutions of TC -71 cDNA. All samples were run in triplicate. Reactions are characterized by the point during cycling when amplification of the PCR product is first detected, rather than the amount of PCR product accumulated after a fixed number of cycles. The larger the starting quantity of the target molecule, the earlier a significant increase in fluorescence is observed. The parameter C T ( threshold cycle ) is defined as the fractional cycle number at which the fluorescence generated by cleavage of the probe passes a fixed threshold above baseline. The IGF -IR mRNA is quantified by measuring C T to determine the relative expression. In all the experiments, the threshold value used to determine C T during analysis was kept constant. Data were normalized to GAPDH. The relative IGF -IR mRNA expression was also normalized to a calibrator, consisting of the parental TC -71 mRNA, and calculated by using the formula: 2 À ÁÁCT where ÁC T=C T IGF -IR À C T GAPDH and ÁÁC T =ÁC t sample À ÁCT calibrator. All samples were resolved in a 2% agarose gel to confirm the PCR specificity.
Western blot
Proteins were extracted from different cell lines maintained at 358C (controls ) and 39.68C for 72 hours by using NP40 1% lysis buffer [10 mM Tris -HCl ( pH 7.4 ), 150 nM NaCl, 50 mM EDTA, IGEPAL 1%, 1 mM PMSF, 10 g/mL Aprotinin, 0.2 mM Na 3 VO 4 ] and sonication. The concentration of total protein was measured using the Bio -Rad ( Munich, Germany ) protein assay, according to the method of Bradford. 18 Equal amounts of protein (60 g ) were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis with an 8% separation gel at 130 V for 60 minutes and transferred at 42 V for 90 minutes to nitrocellulose sheets. Blots were incubated with antihIGF-IR -antibody (Santa Cruz Biotechnology, Santa Cruz, CA; 1/ 1000 dilution ), and then with the horseradish peroxidase -linked secondary antibody (Dako, Glostrup, Denmark; 1/ 1500 dilution ), revealed by ECL Western blotting detection reagents ( Amersham, Aylesbury, UK ). The same blot was stripped and reprobed with the monoclonal antibody for actin protein ( Chemicon International, Temecula, CA; diluted 1: 1000 ).
In vitro growth
To study the effects of IGF -IR down -regulation, 20,000 cells/cm 2 were seeded in IMDM plus 10% FCS and incubated at 35 and 39.68C. After 24 hours, medium was changed with IMDM plus 1% FCS, or IMDM plus 1% FCS with IGF -I ( 50 ng /mL; United Biomedical, Lake Placid, NY ). Cell growth was evaluated on harvested cells by trypan blue vital cell count.
Poly -2 -hydroxyethylmethacrylate ( poly -HEMA ) assay
Six -well plates were treated with poly -HEMA ( Sigma) following the Folkman and Moscona method. 19 Briefly, wells were treated with a 1-mL solution of poly -HEMA diluted in ethanol 95% ( 12 mg /mL ) and left to dry at room temperature. Before use, poly -HEMA -coated dishes were washed twice in phosphate -buffered solution ( PBS ) and once in Hank's solution. Seeded were 100,000 cells / well in IMDM 1% FCS and incubated at 39.68C in a humidified 5% CO 2 atmosphere. Viable and dead cells were counted after 24, 48, and 72 hours. 
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Soft agar assay
Anchorage -independent growth was determined in 0.33% agarose ( SeaPlaque; FMC BioProducts, Rockland, ME ) with a 0.5% agarose underlay. One thousand and 3,300 cells were plated in semisolid medium ( IMDM 10% FCS plus agar 0.33% ) and incubated at 39.68C in a humidified 5% CO 2 atmosphere. Colonies were counted after 6 days. 
Motility assay
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Antisense IGF-IR effectiveness in Ewing's sarcoma K Scotlandi et al performed using Transwell chambers ( Costar, Cambridge, MA ) with 8 -m pore size, polyvinylpyrrolidone -free, polycarbonate filters ( Nucleopore, Pleasanton, CA ). IMDM plus 10% FCS alone or IMDM plus 10% FCS with IGF -I ( 50 ng /mL ) (United Biomedical ) were placed in the lower compartment of the chamber. 10 5 cells in IMDM plus 10% FCS were then seeded in the upper compartment and incubated for 18 hours at 39.68C. Cells migrated towards the filter to reach the lower chamber base and were counted after Giemsa staining. All of the experiments were made in triplicate.
In vitro sensitivity to doxorubicin ( DXR ) 20,000 cells /cm 2 were seeded in IMDM 10% FCS and incubated at 39.68C in a humidified 5% CO 2 atmosphere. After 24 hours, medium was changed with IMDM 10% FCS containing different concentrations of DXR (100 pg/mL -100 ng/ mL ) (Sigma). Cells were harvested and counted after 72 hours of treatment to estimate the percentage of growth inhibition compared to the appropriate controls. Moreover, anchorage -independent growth of IGF -IR sense and antisense transfectants was also analyzed after exposure to DXR. Briefly, cells were exposed to different concentrations of DXR for 16 hours -a time corresponding to the doubling time of these cells -seeded in semisolid medium following the same procedures that were described above, and colonies were counted after 6 days.
Tumorigenic and metastatic ability in athymic mice
Female athymic 4 -to 5 -week -old Crl:nu /nu (CD -1) BR mice ( Charles River Italia, Como, Italy ) were used. Tumorigenicity was determined after subcutaneous ( s.c. ) injection of 5Â10 6 cells. Tumor growth was assessed once a week by measuring tumor volume, calculated as /6½ ffiffiffiffiffiffiffiffiffi ðabÞ p 3 , where a and b are the two major diameters. For ethical reasons, mice were sacrificed and necropsied when the mean tumor volume was 5 mL. Tumors were fixed in 10% buffered formaldehyde for at least 48 hours and processed for histological examination. Tumor sections were stained with hematoxylin and eosin, and analyzed microscopically. The metastatic ability was determined by injection of 2.5Â10 6 viable cells in a tail lateral vein. Two months later, mice were sacrificed. The number of experimental pulmonary metastases was determined by counting with a stereomicroscope after staining with black India ink. The experimental procedures were approved by the local ethical committee and were performed according to the latest version of the Declaration of Helsinki. 
Statistical analysis
Differences among means were analyzed using Student's t test. Wilcoxon's rank sum test and Fisher's exact test were used for frequency data. Kaplan -Meier plots and log -rank test were used to evaluate the survival of mice injected with
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Results
Characterization of IGF -IR antisense ( AS ) -transfected clones
ES tumor cells were transfected with a vector where IGF -IR cDNA was expressed in the antisense or sense orientations under the control of a Drosophila HSP70 promoter. Among the several IGF -IR antisense clones (AS ) obtained, three were selected and studied in comparison with parental TC -71 cells and IGF -IR sense control transfectant cells (S ). The presence of antisense plasmid in genomic DNA of AS transfectants was demonstrated by PCR ( Fig 1 ) . The expression of IGF -IR appeared to be reduced in TC /AS transfectants in comparison with parental cells and TC /S clones, both at mRNA and protein level, as shown by realtime PCR ( Fig 2) and Western blotting (Fig 3 ) . Approximately 30 -65% down -regulation of IGF -IR expression, normalized to the expression of actin, was observed by Western blotting in TC / AS clones.
In vitro growth features of TC -71 cells expressing antisense RNA to IGF -IR
The proliferation ability of TC / AS transfectants was comparable to that of parental and TC / S cells at 358C, whereas it was impaired at 39.68C ( Fig 4, A and B ) when cells were maintained in low serum medium. No significant differences were observed in the growth rate when cells were maintained in 10% FCS -containing medium (data not shown ). TC /AS clones showed a lower growth dependence on exogenous IGF -I ( Fig 5 ) .
To analyze the effects of IGF -IR impairment on ES cell survival, independently of mitogenesis, we evaluated survival and apoptotic rate of TC /AS transfectants in poly -HEMA -coated dishes -a method originally proposed by Folkman and Moscona 19 that was reported to induce anoikis (apoptotic death of cells prevented to adhere to extracellular matrix ). 20, 21 Under these conditions, the survival of TC /AS transfectants was severely reduced ( Fig 6A ) and the occurrence of apoptosis was significantly higher, as documented by annexin test (Fig 6B) . When cells were prevented to adhere, IGF -IR impairment was more critical for anchorage -independent growth, i.e., colony 
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Moreover, antisense strategies against IGF -IR significantly affected the migratory ability of TC -71 cells. In fact, TC /AS transfectants showed a remarkably reduced mitogenicity, both when complete medium alone was used as a chemoattractant (Fig 7) and when IGF -I was added ( data not shown ).
In vivo growth of TC -71 cells expressing antisense RNA to IGF -IR
Tumorigenicity of TC -71 cells stably transfected with sense or antisense plasmids was examined after s.c. injection of parental cells and TC / S and TC / AS transfectants in athymic mice. All animals developed local tumors. However, in animals injected with TC /AS cells, tumor appearance was delayed ( latency time: 13 ± 1 and 17 ± 2 days for TC -71 and TC / S31 cells; 22 ± 4 and 28 ± 5 days for TC /AS25 and TC / AS21, respectively; P <.01 with respect to parental cells ) and tumor growth was slowed down (Fig 8) . Four of five nude mice injected with TC /AS21 and one of five mice injected with TC /AS25 showed a remarkably lower growth rate with respect to controls. Survival was prolonged as well (Fig 9 ) . To test the effect of IGF -IR impairment on the metastatic ability of ES cells, athymic mice were inoculated intravenously ( i.v.) via the tail vein with 2.5Â10
6 tumor cells. ES shows a high tendency to an early metastatic spread with a specific pattern of tissue distribution to lungs and /or bone. We have previously shown that TC -71 cells preferentially colonize to the skeleton after i.v. inoculation. 23 TC /AS transfectants showed a reduced metastatic ability. In fact, the incidence of metastases was reduced, both to the lungs ( 22% in animals injected with parental cells vs 0% in mice injected with TC / AS clones ) and the skeleton (Fig 10 ) . Furthermore, the time of appearance of extrapulmonary metastases was significantly delayed ( 44 ±2 and 46 ± 3 days for TC -71 and TC /S31 cells vs 60 ± 3 and 62 days for TC / AS25 and TC /AS21, respectively; P <.01, Student's t test ). Similarly to tumorigenicity, TC /AS21 TC-71 
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Effects of IGF -IR antisense on ES chemosensitivity
The sensitivity of TC /AS clones to DXR, a key drug in the treatment of ES, was enhanced both in monolayer and in soft agar conditions. Figure 11 shows the significantly higher sensitivity of TC /AS transfectants to different doses of DXR compared to controls in conventional cytotoxic tests ( A ) and in soft agar clonogenic assays (B ) (P < .05, Student's t test ).
Discussion
ES cells provide a good model for the study of IGF -I regulation and effectiveness of strategies aimed at IGF -IR impairment. These cells secrete IGF -I and express IGF -IR, 10, 11, 24 which may account for autonomous cell growth, while maintaining a slight responsiveness to exogenous IGF -I. 13 Furthermore, of several autocrine circuits analyzed, only the IGF -IR -mediated loop is constantly present both in cell lines and clinical samples, 11 suggesting a role for this autocrine circuit in the pathogenesis of ES. Accordingly, Toretsky et al 12 have reported that IGF -IR expression is necessary for the transformation of primary fibroblasts by EWS-FLI -1, the genetic hallmark of ES cells. Consistent with these studies, a recent paper has shown that the most common type of EWS/ FLI -1 fusion transcript, type 1, which is linked to a more favorable prognosis, 25 is also significantly associated with a lower proliferation rate of ES cells, possibly mediated by the differential regulation of IGF -IR pathways. 26 The importance of IGF -IR in modulating the malignant potential of ES cells has been further confirmed by the demonstration that an IGF -IR blocking antibody can reduce the growth and increase apoptosis both in vitro and in vivo, resulting in a significant inhibition of clonogenicity in soft agar, tumorigenicity and metastatic ability. 11, 13 The migration ability of ES cells is also significantly reduced following IGF -IR impairment. 11 Finally, IGF -IR has been recently shown to protect ES cells from drug -induced apoptosis through PI 3-K and Akt survival signaling pathway. 27 In this paper, we evaluated the effectiveness of IGF -IR antisense strategies both in vitro and in vivo by transfecting TC -71 ES cells. This cell line, besides forming tumors in nude mice, is also a good experimental model for bone and lung metastases 23 because it mimics the pattern of metastatic ES involvement in humans.
Transfection with antisense sequences for growth factor receptors is effective in decreasing receptor expression and cell proliferation of neoplastic cells. Several models have been reported for IGF -IR in different neoplasms, 14,15,28 -32 but no data were insofar reported on ES cells.
Antisense IGF -IR transfection produced clones with a moderately decreased IGF -IR expression, rather than fully negative phenotypes. The decrease in IGF -IR level obtained, however, was sufficient to determine an inhibition of the growth rate and a marked enhancement of apoptosis in vitro.
In agreement with previous results, 14, 15, 31, 32 which showed that IGF -IR has a more profound influence on the transformed phenotype than on cellular proliferation, we also found that the antisense strategy was more effective in inhibiting growth of TC -71 ES cells in soft agar than in monolayer conditions. In addition, the survival of TC /AS clones was severely impaired when cells were prevented to adhere to an extracellular matrix, and a significant increase in apoptosis due to anoikis was also observed, further Figure 10 Metastatic ability to extrapulmonary sites of TC -71 and transfected cells. 2.5Â10 6 cells were injected i.v. and metastases were evaluated 2 months after cell injection. Bars represent the median number of metastases; figure reports the number of mice with metastases / total number of mice. TC / S, sense -transfected clones; TC / AS, antisense -transfected clones. Significance: *P < .05, Wilcoxon's rank sum test with respect to TC / S31; **P < .05, Wilcoxon's rank sum test with respect to TC -71 or TC / S31; ***P < .05, Fisher's test with respect to TC -71 or TC / S31.
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Antisense IGF-IR effectiveness in Ewing's sarcoma K Scotlandi et al supporting the view of IGF -IR as an important factor in the regulation of apoptosis in mammalian cells. 33 The significant decrease of anchorage -independent growth in soft agar by TC / AS clones suggests that the malignant phenotype of ES cells has been reversed after treatment with antisense IGF -IR. These findings, together with the observed significant in vitro reduction of TC / AS motility, supported the possibility that IGF -IR impairing strategies may have an effective role also in vivo. Indeed, we demonstrated a significant delay in tumor formation and a reduction in the in vivo growth rate of TC /AS tumors. Moreover, colony formation, after i.v. injection of TC -71 cells, was significantly impaired. Lung colonies were never observed in mice injected with TC / AS cells. The formation of extrapulmonary colonies was significantly delayed, and their incidence and number were significantly lower in the two TC /AS clones examined. The in vivo inhibitory effects were particularly evident for the TCAS21 transfectant, in agreement with the lower in vitro mitogenic and anchorageindependent growth ability of this clone in comparison with the others. However, compared with the treatment effects of antisense plasmids stably transfected in other cell systems, the in vivo effectiveness of IGF -IR antisense strategies in ES cells is not striking. Several factors may be invoked in interpreting our findings. ES cells produce IGF -I and the antisense -transfected cells expressed residual levels of IGF -IR. It is therefore possible that, under conditions of high cell density, autocrine mechanism of stimulation was sufficient to rescue the subpopulation of cells expressing the required threshold level of IGF -IR, eventually giving rise to tumors. This is consistent with the observation that the latent period preceding the appearance of tumors is prolonged in TC / AS clones compared to controls. In addition, TC -71 cells show a higher malignant potential compared to other cell models in nude mice. If a more effective inhibition of receptor expression could be achieved (perhaps with more efficient vectors, or, alternatively, by the use of dominant negative constructs ), the magnitude of the effect could be improved. Furthermore, the antitumor effects observed for antisense IGF -IR plasmids in syngeneic animal model systems are the result of a still poorly defined immunity induction besides the reduction of IGF -IR, which would not play a role in this human tumor xenograft model.
From a clinical point of view, to be of significant therapeutic value, targeted strategies need to be effectively combined with conventional chemotherapeutic drugs. Most anticancer agents, including DXR, kill cancer cells by inhibiting cell cycle and/ or inducing apoptosis. 34, 35 Apoptotic action of chemotherapeutic drugs has been extensively studied in the last few years, and has been claimed to be their main mechanism of action. On the other hand, IGF -IR, activated by its ligands, is emerging as a powerful inhibitor of apoptosis induced by a variety of agents, including anticancer drugs, and ionizing and nonionizing radiation. 36 -39 In ES, a recent study clearly indicates that IGF -I can act as a survival factor and that activation of IGF -IR renders the cells more resistant to DXR -induced apoptosis. 27 Therefore, impairment of IGF -IR functions may sensitize ES cells to apoptosis induced by chemotherapeutic drugs, therefore potentiating their cytotoxic action. Indeed, we found that chemosensitivity against DXR, a major drug for the treatment of ES patients, is significantly higher in IGF -IR AS clones with respect to controls, confirming that the disruption of IGF -IR may potentiate the effects of chemotherapeutic agents.
Taken together, these findings indicate that the inhibition of IGF -IR by antisense strategies may be relevant to the clinical treatment of ES patients by increasing the possibility of curing these neoplasms with strategies aimed at IGF -IR inactivation. When combined with the development of viral vectors designed to deliver genetic information with high efficiency, these strategies could form the basis for the development of highly specific, antimetastatic therapies in patients with ES. 
